Aclaris Therapeutics, Inc. - COM (ACRS)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
50.9M
Holdings value Q3 2024
$58.5M
Value change Q3 2024
-$1.74M
Grand Portfolio weight change Q3 2024
0%
Number of holders
76
Number of buys Q3 2024
29
Number of sells Q3 2024
-49
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 50.9M $58.5M -$1.74M $1.15 76
2024 Q2 52.8M $58.1M -$1.61M $1.10 92
2024 Q1 54.4M $67.4M -$3.79M $1.24 93
2023 Q4 58.4M $61.4M -$207M $1.05 102
2023 Q3 70.1M $480M -$28.1M $6.85 141
2023 Q2 71M $736M +$5.84M $10.37 132
2023 Q1 71.6M $579M +$19.6M $8.09 150
2022 Q4 65.8M $1.04B -$2.54M $15.75 126
2022 Q3 63.6M $1B +$4.2M $15.74 123
2022 Q2 63.3M $883M +$55.2M $13.96 113
2022 Q1 59.3M $1.02B +$59.4M $17.24 108
2021 Q4 56M $815M -$39.8M $14.54 133
2021 Q3 56.8M $1.02B +$15.3M $18.00 126
2021 Q2 56M $983M +$20.6M $17.56 131
2021 Q1 45.4M $1.3B +$509M $25.20 96
2020 Q4 31.9M $207M +$27.7M $6.47 79
2020 Q3 25.6M $65.7M -$3.89M $2.57 53
2020 Q2 28.5M $46.1M -$5.51M $1.62 56
2020 Q1 32.1M $33.4M +$3.16M $1.04 65
2019 Q4 30.8M $58.2M +$3.33M $1.89 72
2019 Q3 29.1M $31.4M -$19.2M $1.08 76
2019 Q2 35.6M $78M -$16.3M $2.19 81
2019 Q1 37.9M $227M -$10.9M $5.99 90
2018 Q4 39.1M $289M +$36.6M $7.39 94
2018 Q3 29.7M $431M -$29.5M $14.52 80
2018 Q2 31M $619M +$11.7M $19.97 91
2018 Q1 30.6M $536M +$33.8M $17.52 99
2017 Q4 28.5M $703M -$10.6M $24.66 101
2017 Q3 27M $695M +$71.5M $25.81 102
2017 Q2 25.6M $694M +$45.1M $27.12 102
2017 Q1 23.7M $706M +$73.3M $29.82 111
2016 Q4 21.4M $579M +$96.5M $27.14 100
2016 Q3 15.5M $396M +$5.2M $25.61 59
2016 Q2 15.4M $283M +$12.2M $18.47 47
2016 Q1 14.6M $277M +$2.04M $18.95 34
2015 Q4 10.3M $277M +$277M $26.94 31